4D Molecular Therapeutics (FDMT)

• Market cap: $477M
• 1 day: -0.11%
• 5 days: 4.82%
• 1 month: 18.96%
• 3 months: -9.05%
• 6 months: 40.18%
• Year to date: 27.73%
• 1 year: 98.09%
• 5 years: -79.32%
• 10 years: -76.91%
• Sector: Healthcare
• Industry: Biotechnology

About: 4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Employees: 227